first generation glp 1 GLP-1: Transforming weight loss and the food industry Timeline of GLP-1 discovery and
Description
Weight loss and appetite suppression are the real indicators that your medication is working, independent of digestive symptoms

Eli Lillys orforglipron, an oral small molecule, not a peptide is expected to receive FDA approval this year and has already prompted Lilly to build three new dedicated manufacturing facilities in the United States (Prime Therapeutics, 2025)

The reason is that the healthcare industry went through a substantial boom from mid-2020 through to late 2021, or perhaps even mid-2022 (coined the covid dividend),(13) and a market correction since then

Zepbound is also FDA-approved to treat sleep apnea in patients with obesity, while Wegovy is FDA-approved to treat cardiovascular disease

In the context of diverticular disease, constipation is more than just an inconvenience
